Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation

Battipaglia G.; Ruggeri A.; Brissot E.; Mamez A-C; Malard F.; Belhocine R.; Vekhoff A.; Giannotti F.; Ledraa T.; Labopin M.; Rubio M-T; Mohty M.

首页> 外文期刊>Bone marrow transplantation >Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation

【24h】

Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation

机译：romiplostim治疗异基因干细胞移植后持续性血小板减少症的安全性和可行性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2015年第12期|共4页
作者
Battipaglia G.; Ruggeri A.; Brissot E.; Mamez A-C; Malard F.; Belhocine R.; Vekhoff A.; Giannotti F.; Ledraa T.; Labopin M.; Rubio M-T; Mohty M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation [J] . Battipaglia G., Ruggeri A., Brissot E., Bone marrow transplantation . 2015,第12期

机译：romiplostim治疗异基因干细胞移植后持续性血小板减少症的安全性和可行性
2. Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children [J] . Maximova Natalia, Zanon D., Rovere F., International journal of hematology . 2015,第5期

机译：Romiplostim治疗异基因干细胞移植后继发性血小板减少症
3. Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation [J] . Limei Michelle Poon, Antonio Di Stasi, Uday Popat, American Journal of Blood Research . 2013,第3期

机译：Romiplostim用于异基因干细胞移植后延迟的血小板恢复和继发性血小板减少
4. Is High-Dose Chemotherapy Plus Stem-Cell Transplant the Standard Treatment for Patients Failing First-Line Chemotherapy for Metastatic Germ Cell Tumor? [C] . Christian Kollmannsberger, Lawrence Einhorn, Craig Nichols Genitourinary Cancers Symposium. . 2014

机译：高剂量化疗加干细胞移植对转移细胞肿瘤的一线化疗失败的患者的标准治疗吗？
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation [O] . Limei Michelle Poon, Antonio Di Stasi, Uday Popat, 2013

机译：Romiplostim用于异基因干细胞移植后延迟的血小板恢复和继发性血小板减少
7. Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation [O] . G Battipaglia, A Ruggeri, E Brissot, 2015

机译：同种异体干细胞移植后持续血小板减少症患者的HONAPLOSTIM治疗的安全性和可行性

Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation

著录项

引文网络

相似文献

相关主题

期刊订阅